标题
Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS-CoV-2
作者
关键词
-
出版物
npj Vaccines
Volume 6, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-12-20
DOI
10.1038/s41541-021-00419-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Comparison of Subgenomic and Total RNA in SARS-CoV-2 Challenged Rhesus Macaques
- (2021) Gabriel Dagotto et al. JOURNAL OF VIROLOGY
- Protective efficacy of a SARS-CoV-2 DNA vaccine in wild-type and immunosuppressed Syrian hamsters
- (2021) Rebecca L. Brocato et al. npj Vaccines
- Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
- (2021) Merryn Voysey et al. LANCET
- The Key Role of Nucleic Acid Vaccines for One Health
- (2021) Anders Fomsgaard et al. Viruses-Basel
- Immunogenicity of clinically relevant SARS-CoV-2 vaccines in non-human primates and humans
- (2021) P. J. Klasse et al. Science Advances
- An Intramuscular DNA Vaccine for SARS-CoV-2 Decreases Viral Lung Load but Not Lung Pathology in Syrian Hamsters
- (2021) Shanna S. Leventhal et al. Microorganisms
- SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data
- (2021) Dung Nguyen et al. Eurosurveillance
- Covid-19: Longer interval between Pfizer doses results in higher antibody levels, research finds
- (2021) Elisabeth Mahase BMJ-British Medical Journal
- Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
- (2020) Qihui Wang et al. CELL
- Gene of the month: the 2019-nCoV/SARS-CoV-2 novel coronavirus spike protein
- (2020) Tahir S Pillay JOURNAL OF CLINICAL PATHOLOGY
- Virological assessment of hospitalized patients with COVID-2019
- (2020) Roman Wölfel et al. NATURE
- Site-specific glycan analysis of the SARS-CoV-2 spike
- (2020) Yasunori Watanabe et al. SCIENCE
- SARS-CoV-2 infection protects against rechallenge in rhesus macaques
- (2020) Abishek Chandrashekar et al. SCIENCE
- Rapid COVID-19 vaccine development
- (2020) Barney S. Graham SCIENCE
- Development of an inactivated vaccine candidate for SARS-CoV-2
- (2020) Qiang Gao et al. SCIENCE
- DNA vaccine protection against SARS-CoV-2 in rhesus macaques
- (2020) Jingyou Yu et al. SCIENCE
- Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
- (2020) Noe B. Mercado et al. NATURE
- ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
- (2020) Neeltje van Doremalen et al. NATURE
- Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
- (2020) Kizzmekia S. Corbett et al. NEW ENGLAND JOURNAL OF MEDICINE
- Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques
- (2020) Wei Deng et al. SCIENCE
- Estimation of Excess Deaths Associated With the COVID-19 Pandemic in the United States, March to May 2020
- (2020) Daniel M. Weinberger et al. JAMA Internal Medicine
- NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge
- (2020) Mimi Guebre-Xabier et al. VACCINE
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors
- (2019) Luis Teixeira et al. CLINICAL CANCER RESEARCH
- DNA priming and gp120 boosting induces HIV-specific antibodies in a randomized clinical trial
- (2019) Nadine G. Rouphael et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials
- (2018) Martin R Gaudinski et al. LANCET
- A Review of DNA Vaccines Against Influenza
- (2018) Leo Yi Yang Lee et al. Frontiers in Immunology
- Rapid development of a DNA vaccine for Zika virus
- (2016) K. A. Dowd et al. SCIENCE
- Improving DNA Vaccine Performance Through Vector Design
- (2014) James Williams CURRENT GENE THERAPY
- Long term stability of lyophilized plasmid DNA pDERMATT
- (2013) Iris van der Heijden et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- DNA Vaccine Delivered by a Needle-Free Injection Device Improves Potency of Priming for Antibody and CD8+ T-Cell Responses after rAd5 Boost in a Randomized Clinical Trial
- (2013) Barney S. Graham et al. PLoS One
- Antibiotic-free production of a herpes simplex virus 2 DNA vaccine in a high yield cGMP process
- (2013) Jared Nelson et al. Human Vaccines & Immunotherapeutics
- A West Nile Virus DNA Vaccine Utilizing a Modified Promoter Induces Neutralizing Antibody in Younger and Older Healthy Adults in a Phase I Clinical Trial
- (2011) Julie E. Ledgerwood et al. JOURNAL OF INFECTIOUS DISEASES
- Coexpressed RIG-I Agonist Enhances Humoral Immune Response to Influenza Virus DNA Vaccine
- (2010) J. M. Luke et al. JOURNAL OF VIROLOGY
- Simultaneous quantification of five bacterial and plant toxins from complex matrices using a multiplexed fluorescent magnetic suspension assay
- (2009) Diana Pauly et al. ANALYST
- Heterologous prime–boost vaccination
- (2009) Shan Lu CURRENT OPINION IN IMMUNOLOGY
- DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial
- (2009) Suzanne Jones et al. VACCINE
- Current progress of DNA vaccine studies in humans
- (2008) Shan Lu et al. Expert Review of Vaccines
- An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses
- (2008) Alexandre Harari et al. JOURNAL OF EXPERIMENTAL MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More